Kengle er en spennende start-up som spinner ut fra by- og konseptutviklingsselskapet Cityplan. Vi har kompetente og meritterte teknologer i ulike felt, sammen med vårt kreative team av konseptutviklere innenfor ulike eiendoms- og servicerelaterte konsepter. Vi kommer fra et kreativt miljø som beveger oss raskt, er svært beslutningsdyktig og har alltid gjort ting på vår måte.

indyRIOT offers a turnkey Community and Networking Solution that provides complete functionality out of the box. It is white-labeled software as a service (SaaS) that enables our clients to fast launch their own fully branded, independent community. It doesn’t mean you can’t bootstrap off another network, but ultimately, It's your community - Own it!

Hello! We are yne. The consulting company by developers, for developers! We build the consulting house of the future with cutting-edge expertise in front-end development, to create the technology you want to use. Easily. We started Yne with a burning desire to challenge the established consulting industry's way of thinking. Today, we are a forward-leaning and innovative company - by developers, for developers. Yne is a consultancy firm built by consultants. We want to be a small firm where your colleagues are your friends. We want to build a profitable company where the employees also have fun social events.

CatalystOne Solutions is a rapidly growing SaaS company with over 200 passionate employees who all work towards a common goal: enabling businesses to thrive. We don't consider ourselves merely a software supplier, but as a partner who works closely with our customers to ensure they gain the maximum value from their HR solution. That's why we provide consistent support and deliver results beyond expectations. Our purpose is to enable businesses to thrive.

SAVER will make everyone capable to help each other out in real time, across industries, cultures, societies and borders.SAVER is a platform for communication (App) that connects people in real time. You will have the opportunity to get in contact with people nearby that will be able to help you.--When was the last time you needed help?What did you need help for? ​ What did you do?​ ​ What if anyone nearby could provide that help? ​  Let us say within the next 15-20 minutes​  What would that mean to you?​  What would you be willing to pay for it? --Saver is the solution to the problemSAVER makes help in real time possible​ SAVER is a platform for communication that connects people in real time​  You will get the opportunity to connect with people nearby that will be able to help you

Propely er et ungt og nytenkende tech-selskap som leverer revolusjonerende programvare til eiendomsbransjen. Vi skiller oss ut ved å levere en sømløs plattform for kommunikasjon mellom utleiere, leietakere og leverandører, en plattform som gir en bedre og mer effektiv drift av eiendommer, samt mer fornøyde brukere av byggene.

You are not a product. Why let your inbox be sold to advertisers? Fjordmail is your private, secure, and green email service. Fjordmail aims to offer the following:-- Secure and privacy-aware email service with a modern and easy-to-use interface-- Take full control of your inbox and say goodbye to spam through pre-qualification of senders-- One-click access to add additional encryption for sensitive emails-- Protection by strict Norwegian privacy law in addition to EU legislation. Our first customers have already joined Fjordmail with our "minimal viable product" which is already in the market. Our addressable segment of the email market is growing by 40-60% p.a.Click here to find out more about Fjordmail

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

BusinessClass.com is a sophisticated travel tech startup. Our vision is to become the global leader in premium travel by offering the best travel search, the best travel offers, as well as world-class reviews and other inspirational content. BusinessClass.com is targeting the more quality-minded travellers who want the best travel products at the best possible prices. BusinessClass.com is suitable for both corporate & leisure travel, offering top-quality airline tickets and accommodation. The team and advisers at BusinessClass.com have extensive travel tech industry knowledge. Founder Jason Eckhoff was EY Entrepreneur Of The Year in 2013 when his first online travel company had beaten 28.000 growth companies over a 4-year period. BusinessClass.com is (other than the founder/CEO) backed by a former C-level manager of a major airline and a co-founder of a unicorn (a company valued at more than 1 USD billion). We are currently considering raising additional risk capital for further developing BusinessClass.com and creating the world's best search engine for premium travel!

Fishency Innovation can give access to the entire salmon industry to affordable equipment to count automatically sea lice in the cage. Monitoring sea lice is the key to controlling them, it is access to good decision support for optimized treatments and to a reliable tool to measure the efficiency of preventive measures and existing treatments. Today, sea lice are counted manually over 20 fish, every week, in each cage. It is labor-demanding, and the collected data are not reliable. Sustainability starts with good data.

Instant cooperation with emergency callers and with patients. You and your team deserve to have the best tools for learning. We prepare you for high-intensity meetings with patients and for time-intensive interactions with other healthcare professionals. Communication in high-intensity situations. For experienced health care professionals.

Appivate is a Norwegian company that develops mobile applications. Our primary developing tool is Appcelerator Studio, a program that lets us write a single code and translate it to native Android and iOS at runtime. This makes the development time- and cost-efficient. The primary goal is to satisfy the customers in every single project and to deliver a product that reflects the client´s vision. To ensure that we are on the right path we usually advise our customers to start with a prototype made with a sketch and envision. This makes it easy to determine if the customer and we are on the same wavelength.

Our vision is to help industry and nature to coexist. 🦅 With the current pressure on nature, biodiversity management is bound to see a new wave of regulations and increased pressure on industry to monitor, measure and reduce its impact. We help industry tackle this challenge with our proprietary biodiversity monitoring technology.

Sereluna designs and sells its own menstrual underwear for the Norwegian market. We are the first menstrual underwear brand in Norway. Menstrual underwear has built in protection and is designed to be washed and reused for several years. Menstrual underwear completely replaces disposable protection like pads and tampons. The reason why Sereluna was created was to offer ladies in Norway a sustainable and more comfortable choice when they have their period. Our whole value chain is within Europe.